157 related articles for article (PubMed ID: 33060663)
1. Intracellular optical doppler phenotypes of chemosensitivity in human epithelial ovarian cancer.
Li Z; An R; Swetzig WM; Kanis M; Nwani N; Turek J; Matei D; Nolte D
Sci Rep; 2020 Oct; 10(1):17354. PubMed ID: 33060663
[TBL] [Abstract][Full Text] [Related]
2. Intracellular Doppler Signatures of Platinum Sensitivity Captured by Biodynamic Profiling in Ovarian Xenografts.
Merrill D; An R; Sun H; Yakubov B; Matei D; Turek J; Nolte D
Sci Rep; 2016 Jan; 6():18821. PubMed ID: 26732545
[TBL] [Abstract][Full Text] [Related]
3. Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index.
Hetland TE; Kærn J; Skrede M; Sandstad B; Tropé C; Davidson B; Flørenes VA
Cancer Chemother Pharmacol; 2012 May; 69(5):1307-14. PubMed ID: 22302409
[TBL] [Abstract][Full Text] [Related]
4. miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer.
Wang T; Hao D; Yang S; Ma J; Yang W; Zhu Y; Weng M; An X; Wang X; Li Y; Wu D; Tang J; Yang C; He Y; Zhang L; Jin X; Wang G; Li Z; Zheng T; Meng H; Feng Y; Li X
Cell Death Dis; 2019 Jun; 10(7):495. PubMed ID: 31235732
[TBL] [Abstract][Full Text] [Related]
5. FOXO3a Reverses the Cisplatin Resistance in Ovarian Cancer.
Lu M; Chen X; Xiao J; Xiang J; Yang L; Chen D
Arch Med Res; 2018 Feb; 49(2):84-88. PubMed ID: 29716743
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer.
Guadagni S; Clementi M; Masedu F; Fiorentini G; Sarti D; Deraco M; Kusamura S; Papasotiriou I; Apostolou P; Aigner KR; Zavattieri G; Farina AR; Vizzielli G; Scambia G; Mackay AR
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32646060
[TBL] [Abstract][Full Text] [Related]
7. Clinical Value of
Hynninen J; Laasik M; Vallius T; Kemppainen J; Grönroos S; Virtanen J; Casado J; Hautaniemi S; Grenman S; Seppänen M; Auranen A
Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):507-514. PubMed ID: 29753662
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein.
Narayanan G; Merrill D; An R; Nolte DD; Turek JJ
Biochem Biophys Res Commun; 2019 Jul; 514(4):1154-1159. PubMed ID: 31103263
[TBL] [Abstract][Full Text] [Related]
9. Heat Shock Protein 60 (HSP60) Serves as a Potential Target for the Sensitization of Chemoresistant Ovarian Cancer Cells.
Harper AK; Fletcher NM; Fan R; Morris RT; Saed GM
Reprod Sci; 2020 Apr; 27(4):1030-1036. PubMed ID: 32124395
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
11. [Research advances on the role of exosomes in chemotherapy resistance of ovarian cancer].
Shen X; Lyu W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 May; 48(1):116-120. PubMed ID: 31102366
[TBL] [Abstract][Full Text] [Related]
12. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
13. [Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa].
Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
Bull Cancer; 2019 Apr; 106(4):354-370. PubMed ID: 30850152
[TBL] [Abstract][Full Text] [Related]
14. Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications.
Khairallah AS; Genestie C; Auguste A; Leary A
Int J Cancer; 2018 Jul; 143(1):8-15. PubMed ID: 29218796
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion.
Koren Carmi Y; Mahmoud H; Khamaisi H; Adawi R; Gopas J; Mahajna J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906729
[TBL] [Abstract][Full Text] [Related]
16. TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers.
Ghisoni E; Maggiorotto F; Borella F; Mittica G; Genta S; Giannone G; Katsaros D; Sciarrillo A; Ferrero A; Sarotto I; Erriquez J; Di Renzo MF; Aglietta M; Valabrega G
J Ovarian Res; 2019 Feb; 12(1):17. PubMed ID: 30760286
[TBL] [Abstract][Full Text] [Related]
17. [The mRNA expression of BRCA1, ERCC1, TUBB3, PRR13 genes and their relationship with clinical chemosensitivity in primary epithelial ovarian cancer].
Zhao D; Zhang W; Li XG; Wang XB; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):196-200. PubMed ID: 22780973
[TBL] [Abstract][Full Text] [Related]
18. Role of Extracellular Vesicles in Epithelial Ovarian Cancer: A Systematic Review.
Lucidi A; Buca D; Ronsini C; Tinari S; Bologna G; Buca D; Leombroni M; Liberati M; D'Antonio F; Scambia G; Lanuti P; Petrillo M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228245
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer.
Ryner L; Guan Y; Firestein R; Xiao Y; Choi Y; Rabe C; Lu S; Fuentes E; Huw LY; Lackner MR; Fu L; Amler LC; Bais C; Wang Y
Clin Cancer Res; 2015 Jul; 21(13):2941-51. PubMed ID: 25838397
[TBL] [Abstract][Full Text] [Related]
20. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
